← Back to Search

Pain Management Training for Musculoskeletal Pain

N/A
Recruiting
Led By Michael E Robinson, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants with WMP must meet the ACR (2010) diagnostic criteria of multiple regions of muscle pain
Asymptomatic people (ie no current pain conditions)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline up to 10 weeks
Awards & highlights

Study Summary

This trial will study how people's bodies naturally manage pain, and if this can be improved through training.

Who is the study for?
This trial is for adults with widespread muscle pain who meet the ACR diagnostic criteria and those without any current pain or chronic conditions like IBS. It excludes individuals who've trained their biceps recently, had recent arm pain, used other pain interventions, have metal in their body that affects MRI, certain chronic medical conditions, or are pregnant.Check my eligibility
What is being tested?
The study aims to understand why people experience different levels of musculoskeletal pain and if it's possible to 'train' the body to manage this pain better. This involves looking at natural variations in how we handle discomfort and trying out methods to improve this ability.See study design
What are the potential side effects?
Since the intervention involves training similar to physical exercise (delayed onset muscle soreness), side effects may include temporary increased muscle soreness or discomfort as a result of the activities involved in the study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have muscle pain in multiple areas, as diagnosed by ACR criteria.
Select...
I currently do not have any pain.
Select...
I do not have current pain in my wrist, hand, elbow, or shoulder and no chronic pain conditions.
Select...
I am 18 or older with widespread muscle pain.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline up to 10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline up to 10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain
Change in pressure quantitative sensory testing
Change in thermal quantitative sensory testing
Secondary outcome measures
Cortical network connectivity

Trial Design

3Treatment groups
Active Control
Group I: Single exposureActive Control1 Intervention
Participants will complete one exercise session designed to induce delayed onset muscle soreness
Group II: Natural historyActive Control1 Intervention
Participants will complete all sensory testing and imaging but not perform any exercise sessions.
Group III: Repeated exposureActive Control1 Intervention
Participants will complete four exercise sessions designed to induce delayed onset muscle soreness in the biceps

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,338 Previous Clinical Trials
715,136 Total Patients Enrolled
7 Trials studying Musculoskeletal Pain
1,305 Patients Enrolled for Musculoskeletal Pain
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
483 Previous Clinical Trials
1,086,759 Total Patients Enrolled
5 Trials studying Musculoskeletal Pain
708 Patients Enrolled for Musculoskeletal Pain
Michael E Robinson, PhDPrincipal InvestigatorUniversity of Florida
1 Previous Clinical Trials
50 Total Patients Enrolled

Media Library

Single exposure Clinical Trial Eligibility Overview. Trial Name: NCT04441619 — N/A
Musculoskeletal Pain Research Study Groups: Single exposure, Natural history, Repeated exposure
Musculoskeletal Pain Clinical Trial 2023: Single exposure Highlights & Side Effects. Trial Name: NCT04441619 — N/A
Single exposure 2023 Treatment Timeline for Medical Study. Trial Name: NCT04441619 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants being admitted to this research project at present?

"Affirmative. Clinicaltrials.gov confirms that the medical research, which was first advertised on November 30th 2020, is currently enrolling participants. Approximately 180 individuals are needed to participate at 1 centre of trial recruitment."

Answered by AI

What is the approximate number of persons involved in this experiment?

"Affirmative. According to details found on clinicaltrials.gov, the trial that first appeared on November 30th 2020 is still actively recruiting participants. The research requires 180 individuals across a single centre for completion."

Answered by AI

Are participants aged twenty-five and above accepted for this trial?

"To be eligible for this medical study, participants must fall into the age bracket of 18-70. There are separate initiatives catering to those below 18 and adults over 65; 8 studies and 47 respectively."

Answered by AI

Who meets the prerequisites to take part in this medical trial?

"This clinical trial seeks 180 adults aged 18 to 70 who are suffering from musculoskeletal pain. In addition, participants must have no current wrist/hand, elbow or shoulder discomfort and not be diagnosed with any chronic ailments (e.g., irritable bowel syndrome or fibromyalgia). Furthermore, the ACR (2010) diagnostic criteria of multiple regions of muscle tenderness is also a pre-requisite for eligibility."

Answered by AI
~30 spots leftby Nov 2024